|
|
|
NAFLD
J Pediatr Gastroenterol Nutr. 2012 May;54(5):588-93.
LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.
Valenti L, Motta BM, Alisi A, Sartorelli R, Buonaiuto G, Dongiovanni P, Rametta R, Pelusi S, Fargion S, Nobili V.
Department of Internal Medicine, Università degli Studi, Ospedale Maggiore Policlinico Ca' Granda IRCCS, Milan, Italy. luca.valenti@unimi.it
Abstract
OBJECTIVES: The aim of the present study was to evaluate whether the lipin1 rs13412852 C>T polymorphism is associated with nonalcoholic steatohepatitis and fibrosis in pediatric Italian patients with nonalcoholic fatty liver disease (NAFLD).
https://www.ncbi.nlm.nih.gov/pubmed/29670474 NAFLD
Mater Sociomed. 2018 Mar;30(1):20-25. doi: 10.5455/msm.2018.30.20-25.Positive Effect of Fermented Camel Milk on Liver Enzymes of Adolescents with Metabolic Syndrome: a Double Blind, Randomized, Cross-over Trial.Fallah Z1,2, Feizi A3,4, Hashemipour M1,4, Kelishadi R2.
Abstract
BACKGROUND:
Metabolic syndrome (MetS) has several health consequences. Liver enzymes elevation is among them.
AIM:
This study aimed to assess the effects of fermented Camel milk (FCM), as a functional food and dairy, on some features of MetS in adolescents including liver enzymes status, serum lipids and anthropometric measures.
METHODS:
https://pubmed.ncbi.nlm.nih.gov/34580427/ NAFLD
Pediatr Res. 2021 Sep 27.
doi: 10.1038/s41390-021-01754-6. Online ahead of print.
Predictors of non-alcoholic fatty liver disease in children
Menglong Li # 1, Wen Shu # 1, Jiawulan Zunong 1, Nubiya Amaerjiang 1, Huidi Xiao 1, Dan Li 2, Sten H Vermund 2, Yifei Hu 3
Abstract
Objective: Abdominal obesity is strongly associated with the development of non-alcoholic fatty liver disease (NAFLD). Early identification and intervention may reduce the risk. We aim to improve pediatric NAFLD screening by comparing discriminative performance of six abdominal obesity indicators.
https://pubmed.ncbi.nlm.nih.gov/34454951/ NAFLD
J Pediatr. 2021 Aug 26;S0022-3476(21)00826-X.
doi: 10.1016/j.jpeds.2021.08.041.Online ahead of print.
Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Non-Alcoholic Fatty Liver Disease
Ammar Khayat 1, Bernadette Vitola 2
Abstract
Objectives: To evaluate the prevalence and clinical significance of autoantibodies in children with overweight and obesity with non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH) in comparison with those with autoimmune liver disease (ALD).
J Gastroenterol Hepatol. 2012 Oct;27(10):1555-60. doi: 10.1111/j.1440-1746.2012.07222.x.
Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.
Liu CJ.
Source
Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan Department of Internal Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan Hepatitis Research Center, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan.
Abstract
https://pubmed.ncbi.nlm.nih.gov/32712103/ NAFLD
Gastroenterology. 2020 Jul 23;S0016-5085(20)34996-9.
doi: 10.1053/j.gastro.2020.07.034.Online ahead of print.
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice
Stavra A Xanthakos 1, Joel E Lavine 2, Katherine P Yates 3, Jeffrey B Schwimmer 4, Jean P Molleston 5, Philip Rosenthal 6, Karen F Murray 7, Miriam B Vos 8, Ajay K Jain 9, Ann O Scheimann 10, Tamir Miloh 11, Mark Fishbein 12, Cynthia A Behling 13, Elizabeth M Brunt 14, Arun J Sanyal 15, James Tonascia 3, NASH Clinical Research Network
PMID: 32712103
DOI: 10.1053/j.gastro.2020.07.034
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/22925921
J Pediatr Gastroenterol Nutr. 2012 Aug 24. [Epub ahead of print]
Journal of Pediatric Gastroenterology & Nutrition:
January 2013 - Volume 56 - Issue 1 - p 77–82
doi: 10.1097/MPG.0b013e31826f2b8c
Original Articles: Hepatology and Nutrition
Psychosocial Outcomes for Children with Nonalcoholic Fatty Liver Disease over Time and Compared to Obese Controls.
Kerkar N, D'Urso C, Van Nostrand K, Kochin I, Gault A, Suchy F, Miloh T, Arnon R, Chu J, Annunziato R.
Source
https://www.ncbi.nlm.nih.gov/pubmed/31124886 NAFLD
J Pediatr Gastroenterol Nutr. 2019 May 18. doi: 10.1097/MPG.0000000000002401. [Epub ahead of print]
Psychotropic Medications are Associated with Increased Liver Disease Severity in Pediatric NAFLD.
Mouzaki M1, Yodoshi T1, Arce-Clachar AC1, Bramlage K1, Fei L2, Hunsaker SL3, Xanthakos SA1.
Abstract
OBJECTIVES:
To determine whether pediatric patients with non-alcoholic fatty liver disease (NAFLD) exposed to psychotropic medications have more severe liver disease compared to their counterparts who are not on these medications. We hypothesize that use of psychotropic agents is associated with liver disease severity.
METHODS:
https://www.ncbi.nlm.nih.gov/pubmed/29341046
NAFLD
Horm Metab Res. 2018 Jan 16. doi: 10.1055/s-0043-124970. [Epub ahead of print].
Liang S, Yu Z, Song X, Wang Y, Li M, Xue J.
Abstract
https://pubmed.ncbi.nlm.nih.gov/34178902/ NAFLD
Front Pediatr. 2021 Jun 10;9:685795.
doi: 10.3389/fped.2021.685795. eCollection 2021.
Relationship Between Histological Features of Non-alcoholic Fatty Liver Disease and Ectopic Fat on Magnetic Resonance Imaging in Children and Adolescents
Eun Hye Lee 1, Ji Young Kim 2, Hye Ran Yang 3 4
Abstract
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
